EUREPA 2MG TAB
₹375.30
Eurepa 2mg Tablet is a medicine containing Repaglinide, used to treat type 2 diabetes by controlling blood sugar levels.
Description
Eurepa 2mg Tablet contains Repaglinide as its active ingredient. Repaglinide is an oral antidiabetic medication prescribed to individuals with type 2 diabetes. It belongs to the class of drugs known as meglitinides. Eurepa 2mg Tablet helps to control blood sugar levels by stimulating the release of insulin from the pancreas. It aids in lowering high blood sugar levels after meals by regulating insulin secretion, which in turn helps to prevent complications associated with diabetes. The dosage may vary based on the individual’s response to treatment, blood sugar levels, and other medications they may be taking. Eurepa 2mg Tablet is an essential component of a comprehensive treatment plan for type 2 diabetes. It should be used in conjunction with a proper diet, regular exercise, and weight management to effectively manage blood sugar levels.
Additional information
| Marketed by | |
|---|---|
| Composition | |
| Dosage form | TABLET |
| Prescription | REQUIRED |
| Therapeutic use | ANTI DIABETICS |
